Results 191 to 200 of about 236,085 (267)

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

Angewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean, Nicolás Montesdeoca, Gilles Berger, Johannes Karges   +3 more
wiley   +1 more source

A Deep Learning Approach for Classifying Benign, Malignant, and Borderline Ovarian Tumors Using Convolutional Neural Networks and Generative Adversarial Networks. [PDF]

Med Sci (Basel)
Giourga M, Petropoulos I, Stavros S, Potiris A, Goula K, Moustakli E, Papahliou AM, Daskalaki MA, Segou M, Rodolakis A, Daskalakis G, Domali E.   +11 more
europepmc   +1 more source

Clinicopathological Diagnosis and Prognosis of Endometrioid Borderline Ovarian Tumors: Dual Case Reports and Literature Review. [PDF]

Cancer Rep (Hoboken)
Yang F, Chen D, Sun Q, Yu J, Wang X.
europepmc   +1 more source

The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding

Animal Research and One Health, EarlyView.
A schematic workflow illustrating the screening of disease‐resistant miRNAs and the generation of miRNA‐based disease‐resistant chickens via PGC‐mediated germline genome editing. ABSTRACT MicroRNAs (miRNAs) are emerging as pivotal regulators of the immune system, playing a decisive role in shaping disease resistance in chicken.
Qiangzhou Wang, Weiran Wu, Qingqing Cai, Jiaxing Wang, Qi Gao, Muhammad Iftikhar, Yulin Bi, Hao Bai, Lihong Gu, Guobin Chang, Shihao Chen   +10 more
wiley   +1 more source

Ultrasound-based deep learning model as an assistant improves the diagnosis of ovarian tumors: a multicenter study. [PDF]

Insights Imaging
Wang Y, Zhang J, He Y, Wang X, Wu X, Zhang W, Gong M, Gao D, Liu S, Liu P, Li P, Shen L, Lyu G.   +12 more
europepmc   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Proteogenomic approach to immunopeptidomics of ovarian tumors identifies shared peptide vaccine candidates. [PDF]

NPJ Vaccines
Chiaro J, Peltonen K, Õunap K, Bailey A, Feola S, Wojciechowski S, Es-Haghi M, Azkargorta M, Elortza F, Russo S, Sallinen H, Anttila M, Gurvich O, Cerullo V, Kekarainen T.   +14 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

The usefulness of the follicle-preserving sign in differentiating between benign, borderline, and malignant ovarian tumors on magnetic resonance imaging. [PDF]

Jpn J Radiol
Takekoshi D, Ohya A, Fukuzawa T, Maehara M, Yamada A, Fujinaga Y.   +5 more
europepmc   +1 more source

Added value of serum proteins to clinical and ultrasound information in predicting the risk of malignancy in ovarian tumors. [PDF]

iScience
Coosemans A, Ceusters J, Landolfo C, Baert T, Jamil K, Froyman W, Heremans R, Thirion G, Claes S, Oosterlynck J, Wouters R, Vankerckhoven A, Moro F, Mascilini F, Neumann A, Van Rompuy AS, Schols D, Billen J, Van Gorp T, Vergote I, Bourne T, Van Holsbeke C, Chiappa V, Scambia G, Testa A, Fischerova D, Timmerman D, Van Calster B.   +27 more
europepmc   +1 more source